title: Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
authors.forename: Sumitra
authors.initials: S
authors.lastname: Ananda
authors.forename: Kathryn M
authors.initials: KM
authors.lastname: Field
authors.forename: Suzanne
authors.initials: S
authors.lastname: Kosmider
authors.forename: Daniel
authors.initials: D
authors.lastname: Compston
authors.forename: Jayesh
authors.initials: J
authors.lastname: Desai
authors.forename: Lionel C
authors.initials: LC
authors.lastname: Lim
authors.forename: Frances S
authors.initials: FS
authors.lastname: Barnett
authors.forename: Ian T
authors.initials: IT
authors.lastname: Jones
authors.forename: Iain
authors.initials: I
authors.lastname: Skinner
authors.forename: Peter
authors.initials: P
authors.lastname: Gibbs
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D015897:Comorbidity; D005260:Female; D006306:Health Surveys; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*
chemical_list: D000970:Antineoplastic Agents